Equity - Earnings Per Share ("EPS") (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Basic
Net income attributable to common stockholders	$ 62,710	$ 72,804	$ 196,678	$ 211,409
Net income attributable to common stockholders and noncontrolling interest	$ 62,710	$ 72,804	$ 196,678	$ 211,409
Weighted average shares outstanding (in shares)	170,227,553	142,624,300	162,292,235	134,437,663
Weighted average shares outstanding (in shares)	170,227,553	142,624,300	162,292,235	134,437,663
Net income per common share (in dollars per share)	$ 0.37	$ 0.51	$ 1.21	$ 1.57
Diluted
Net income attributable to common stockholders	$ 62,710	$ 72,804	$ 196,678	$ 211,409
Net income attributable to noncontrolling interest	6,002	8,347	19,811	26,806
Interest expense on convertible notes	5,797		13,786
Net income attributable to common stockholders and noncontrolling interest	$ 74,509	$ 81,151	$ 230,275	$ 238,215
Weighted average shares outstanding (in shares)	170,227,553	142,624,300	162,292,235	134,437,663
Dilutive effect of OP Units (in shares)	16,293,589	16,351,643	16,308,361	16,985,073
Dilutive effect of restricted stock units (in shares)	528,475	940,045	558,216	927,542
Dilutive effect of convertible notes (in shares)	18,815,399	354,917	16,370,528	341,183
Weighted average shares outstanding ( in shares)	205,865,016	160,270,905	195,529,340	152,691,461
Diluted earnings per common share	$ 0.36	$ 0.51	$ 1.18	$ 1.56
Mr. Ivan Kaufman | Performance-based restricted stock
Diluted
Vesting period (in years)			4 years